Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: The one centimeter per month rule

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 977-982

  Park, James O ^a   Qin, Li Xuan ^b   Prete, Francesco P ^a   Antonescu, Cristina ^b   Brennan, Murray F ^a   Singer, Samuel ^a  

^a Department of Surgery   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GROWTH RATE; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROPERITONEAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 73449145642     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b2468b     Document Type: Article

References (23)

1. Jaques DP, Coit DG, Hajdu SI, et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg. 1990;212:51-59.
2. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
3. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995; 221:185-195.
4. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg. 1991;214:2-10.
5. Alvarenga JC, Ball AB, Fisher C, et al. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg. 1991;78:912-916.
6. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29: 1005-1010.
7. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2455.
8. Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15:2832-2839.
9. Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329-339.
10. Linehan DC, Lewis JJ, Leung D, et al. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol. 2000;18: 1637-1643.
11. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperito-neal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368.
12. Fletcher CD, Akerman M, Dal Cin P, et al. Correlation between clinicopath-ological features and karyotype in lipomatous tumors: a report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996;148:623-630.
13. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal lipo-sarcoma. Ann Surg. 2003;238:358-370; discussion 370-371.
14. Mazumdar M, Smith A, Bacik J. Methods for categorizing a prognostic variable in a multivariable setting. Stat Med. 2003;22:559-571.
15. McGrath PC, Neifeld JP, Lawrence W Jr, et al. Improved survival following complete excision of retroperitoneal sarcomas. Ann Surg. 1984;200:200-204.
16. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
17. Shibata D, Lewis JJ, Leung DH, et al. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg. 2001; 193:373-379.
18. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523-528.
19. Dachman AH, MacEneaney PM, Adedipe A, et al. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001;91:555-560.
20. Schuetze SM, Baker LH, Benjamin RS, et al. Selection of response criteria for clinical trials of sarcoma treatment. Oncologist. 2008;13(suppl 2):32-40.
21. Benjamin RS. SARC-CTOS imaging symposium: introduction to the problem from a clinical perspective. Oncologist. 2008;13(suppl 2):1-3.
22. Eilber FC, Kattan MW. Sarcoma nomogram: validation and a model to evaluate impact of therapy. J Am Coll Surg. 2007;205(suppl 4):S90-S95.
23. van Dalen T, Plooij JM, van Coevorden F, et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol. 2007;33:234-238.